Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2017

10.09.2016 | Gynecologic Oncology

Preterm delivery and future maternal risk of female malignancies

verfasst von: Roy Kessous, Asnat Walfisch, Mihai Meirovitz, Ehud Davidson, Ruslan Sergienko, Eyal Sheiner

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate whether an association exists between preterm delivery and a future risk for female malignancies.

Methods

A population-based study compared the incidence of long-term female malignancies in a cohort of women with and without a history of PTD. Deliveries occurred between the years 1988–2013, with a mean follow-up duration of 12 years. We excluded women with known genetic predisposition or malignancies prior to the index pregnancy. Malignancies investigated included ovarian, uterine, breast and cervix. Cumulative incidence was assessed using a Kaplan–Meier survival curve. A Cox proportional hazards model was used to estimate the adjusted hazard ratios (HR) for female malignancy.

Results

During the study period, 105,033 women met the inclusion criteria; 16.8 % (n = 17,596) of the patients delivered preterm. Patients with a history of PTD did not have an increased risk of later being diagnosed with female malignancies. The results remained insignificant in a sub-analysis based on malignancy type, early PTD, induced vs. spontaneous, and number of episodes per patient. Kaplan–Meier cumulative incidence was similar between the groups, and the adjusted HR was not significant (1.04, 95 % CI 0.88–1.22; p = 0.665).

Conclusion

A history of PTD does not appear to elevate the risk for subsequent long-term female malignancies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bonamy AK, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E (2011) Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation 124:2839–2846CrossRefPubMed Bonamy AK, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E (2011) Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation 124:2839–2846CrossRefPubMed
2.
Zurück zum Zitat Kessous R, Shoham-Vardi I, Pariente G, Sergienko R, Sheiner E (2015) Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart 101:442–446CrossRefPubMed Kessous R, Shoham-Vardi I, Pariente G, Sergienko R, Sheiner E (2015) Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart 101:442–446CrossRefPubMed
3.
Zurück zum Zitat Kessous R, Shoham-Vardi I, Pariente G, Sergienko R, Sheiner E (2014) Intensified risk for long term maternal cardiovascular morbidity in patients with recurrent and severe preeclampsia. Am J Obstet Gynecol 210(1):S162–S163CrossRef Kessous R, Shoham-Vardi I, Pariente G, Sergienko R, Sheiner E (2014) Intensified risk for long term maternal cardiovascular morbidity in patients with recurrent and severe preeclampsia. Am J Obstet Gynecol 210(1):S162–S163CrossRef
4.
Zurück zum Zitat McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ (2010) Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 55:1026–1039CrossRefPubMed McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ (2010) Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 55:1026–1039CrossRefPubMed
5.
Zurück zum Zitat Gotsch F, Romero R, Erez O et al (2009) The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J Matern Fetal Neonatal Med 22(Suppl 2):5–23CrossRefPubMed Gotsch F, Romero R, Erez O et al (2009) The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J Matern Fetal Neonatal Med 22(Suppl 2):5–23CrossRefPubMed
6.
Zurück zum Zitat Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371:75–84CrossRefPubMed Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371:75–84CrossRefPubMed
7.
Zurück zum Zitat Catov JM, Newman AB, Roberts JM et al (2007) Preterm delivery and later maternal cardiovascular disease risk. Epidemiology 18:733–739CrossRefPubMed Catov JM, Newman AB, Roberts JM et al (2007) Preterm delivery and later maternal cardiovascular disease risk. Epidemiology 18:733–739CrossRefPubMed
8.
Zurück zum Zitat Hoyme UB (2016) Pragmatic prevention of preterm birth and evidence based medicine. Arch Gynecol Obstet 294(1):1–3CrossRefPubMed Hoyme UB (2016) Pragmatic prevention of preterm birth and evidence based medicine. Arch Gynecol Obstet 294(1):1–3CrossRefPubMed
9.
Zurück zum Zitat Sabour S (2015) Prediction of preterm delivery using levels of VEGF and leptin in amniotic fluid from the second trimester: prediction rules. Arch Gynecol Obstet 291(4):719CrossRefPubMed Sabour S (2015) Prediction of preterm delivery using levels of VEGF and leptin in amniotic fluid from the second trimester: prediction rules. Arch Gynecol Obstet 291(4):719CrossRefPubMed
10.
Zurück zum Zitat Xu P, Alfaidy N, Challis JR (2002) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 87:1353–1361CrossRefPubMed Xu P, Alfaidy N, Challis JR (2002) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 87:1353–1361CrossRefPubMed
11.
Zurück zum Zitat Kim A, Lee ES, Shin JC, Kim HY (2013) Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. Placenta 34:873–878CrossRefPubMed Kim A, Lee ES, Shin JC, Kim HY (2013) Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. Placenta 34:873–878CrossRefPubMed
12.
Zurück zum Zitat Seong WJ (2016) Amniotic fluid CA-125 as a marker of intra-amniotic inflammation associated with preterm delivery: a preliminary single center study. Arch Gynecol Obstet 293(1):55–59CrossRefPubMed Seong WJ (2016) Amniotic fluid CA-125 as a marker of intra-amniotic inflammation associated with preterm delivery: a preliminary single center study. Arch Gynecol Obstet 293(1):55–59CrossRefPubMed
13.
Zurück zum Zitat Schüler S, Ponnath M, Engel J, Ortmann O (2013) Ovarian epithelial tumors and reproductive factors: a systematic review. Arch Gynecol Obstet 287(6):1187–1204CrossRefPubMed Schüler S, Ponnath M, Engel J, Ortmann O (2013) Ovarian epithelial tumors and reproductive factors: a systematic review. Arch Gynecol Obstet 287(6):1187–1204CrossRefPubMed
14.
Zurück zum Zitat Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev 13:1558–1568 Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev 13:1558–1568
15.
Zurück zum Zitat Fishman J, Osborne MP, Telang NT (1995) The role of estrogen in mammary carcinogenesis. Ann N Y Acad Sci 768:91–100CrossRefPubMed Fishman J, Osborne MP, Telang NT (1995) The role of estrogen in mammary carcinogenesis. Ann N Y Acad Sci 768:91–100CrossRefPubMed
16.
Zurück zum Zitat Britton JA, Gammon MD, Schoenberg JB et al (2002) Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol 156:507–516CrossRefPubMed Britton JA, Gammon MD, Schoenberg JB et al (2002) Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol 156:507–516CrossRefPubMed
17.
Zurück zum Zitat Zhang ST, Zuo C, Li WN, Fu XQ, Xing S, Zhang XP (2016) Identification of key genes associated with the effect of estrogen on ovarian cancer using microarray analysis. Arch Gynecol Obstet 293(2):421–427CrossRefPubMed Zhang ST, Zuo C, Li WN, Fu XQ, Xing S, Zhang XP (2016) Identification of key genes associated with the effect of estrogen on ovarian cancer using microarray analysis. Arch Gynecol Obstet 293(2):421–427CrossRefPubMed
18.
Zurück zum Zitat Guo S, Russo IH, Lareef MH, Russo J (2004) Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol 24:399–407PubMed Guo S, Russo IH, Lareef MH, Russo J (2004) Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol 24:399–407PubMed
19.
Zurück zum Zitat Koochekpour S, Bullock P, Dean A, Pilkington G, Merzak A (1995) Expression of vascular endothelial growth-factor in the cyst fluid of human cerebral gliomas. Oncol Rep 2:1147–1149PubMed Koochekpour S, Bullock P, Dean A, Pilkington G, Merzak A (1995) Expression of vascular endothelial growth-factor in the cyst fluid of human cerebral gliomas. Oncol Rep 2:1147–1149PubMed
20.
Zurück zum Zitat Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736–741CrossRefPubMed Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736–741CrossRefPubMed
21.
Zurück zum Zitat Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135–1149PubMed Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135–1149PubMed
22.
Zurück zum Zitat Roomi MW, Kalinovsky T, Rath M, Niedzwiecki A (2012) Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines. Oncol Rep 28:768–776PubMedPubMedCentral Roomi MW, Kalinovsky T, Rath M, Niedzwiecki A (2012) Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines. Oncol Rep 28:768–776PubMedPubMedCentral
23.
25.
Zurück zum Zitat Dossus L, Allen N, Kaaks R et al (2010) Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 127:442–451PubMed Dossus L, Allen N, Kaaks R et al (2010) Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 127:442–451PubMed
26.
Zurück zum Zitat Fortner RT, Ose J, Merritt MA et al (2015) Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: results from the EPIC cohort. Int J Cancer 137(5):1196–1208CrossRefPubMed Fortner RT, Ose J, Merritt MA et al (2015) Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: results from the EPIC cohort. Int J Cancer 137(5):1196–1208CrossRefPubMed
28.
Zurück zum Zitat Grisaru-Granovsky S, Gordon ES, Haklai Z, Schimmel MS, Drukker L, Samueloff A, Keinan-Boker L (2015) Delivery of a very low birth weight infant and increased maternal risk of cancer and death: a population study with 16 years of follow-up. Cancer Causes Control 26:1593–1601CrossRefPubMed Grisaru-Granovsky S, Gordon ES, Haklai Z, Schimmel MS, Drukker L, Samueloff A, Keinan-Boker L (2015) Delivery of a very low birth weight infant and increased maternal risk of cancer and death: a population study with 16 years of follow-up. Cancer Causes Control 26:1593–1601CrossRefPubMed
Metadaten
Titel
Preterm delivery and future maternal risk of female malignancies
verfasst von
Roy Kessous
Asnat Walfisch
Mihai Meirovitz
Ehud Davidson
Ruslan Sergienko
Eyal Sheiner
Publikationsdatum
10.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4198-3

Weitere Artikel der Ausgabe 1/2017

Archives of Gynecology and Obstetrics 1/2017 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.